Disclosure Of Effect Of Changes In Foreign Exchange Rates [Text Block]

Biofrontera AG - Filing #6537419

Concept As at
2022-12-31
2022-01-01 to
2022-12-31
2022-01-01 to
2022-12-31
2022-01-01 to
2022-12-31
2022-01-01 to
2022-12-31
2022-01-01 to
2022-12-31
As at
2021-12-31
2021-01-01 to
2021-12-31
2021-01-01 to
2021-12-31
2021-01-01 to
2021-12-31
2021-01-01 to
2021-12-31
2021-01-01 to
2021-12-31
Disclosure of effect of changes in foreign exchange rates [text block]
Das sonstige Ergebnis nach Steuern enthält lediglich Umrechnungsdifferenzen aus der Umrechnung des Geschäftsbetriebs in Fremdwährung in die Konzernwährung.
Description of functional currency
Der Konzernabschluss zum 31. Dezember 2022 wird in EUR (bzw. TEUR), der funktionalen Währung der deutschen in den Konzernabschluss einbezogenen Unternehmen, und der Darstellungswährung des Konzerns, aufgestellt.
Description of presentation currency
EUR
Disclosure of information when currency is not exchangeable into another currency [text block]
Disclosure of information when foreign operation’s functional currency is not exchangeable into presentation currency [text block]
Disclosure of summarised financial information about foreign operation [text block]
Disclosure of summarised financial information about foreign operation [abstract]
Disclosure of summarised financial information about foreign operation [line items]
Non-current assets
17,669 EUR
61,750 EUR
Current assets
15,056 EUR
14,377 EUR
Non-current liabilities
4,002 EUR
1,235 EUR
Current liabilities
8,387 EUR
17,467 EUR
Revenue
25,738 EUR
28,787 EUR
Profit (loss)
0 EUR
44,166 EUR
44,166 EUR
0 EUR
0 EUR
33,286 EUR
Other comprehensive income
0 EUR
0 EUR
0 EUR
0 EUR
0 EUR
0 EUR
0 EUR
1,866 EUR
0 EUR
1,866 EUR
Comprehensive income
0 EUR
44,166 EUR
44,166 EUR
0 EUR
0 EUR
33,286 EUR
0 EUR
1,866 EUR
0 EUR
31,420 EUR

Talk to a Data Expert

Have a question? We'll get back to you promptly.